Objective: During COS for ART many different medications are administered daily by subcutaneous or intramuscular injections. Utilizing the most patient-friendly COS regimen, with oral contraceptive pill pre-treatment, ten days of follicular phase treatment, including one daily dose of rFSH, 4 doses of GnRH antagonist, one dose of hCG and the use of vaginal progesterone, 15 injections will be administered. If GnRH agonist is used for 14–21 days instead of a GnRH antagonist, plus two daily doses of FSH and hMG, plus progesterone in oil, the number of injections is closer to 100. Variables, such as injection technique errors and compliance, are known to affect final treatment outcomes. A variable not widely examined is the precision of drug delivery by the most commonly used syringes. This study was undertaken to determine if there is a true difference between the amount of drug delivered by different brands of syringes, to precisely measure these differences and to detect the origin of these differences. Design: Comparative trial. Materials and Methods: Four syringes were examined from three different suppliers: Becton Dickinson (BD) 3 mL leur-lok, BD and Monoject(r) 1 mL, with detachable 27G × 1/2 inch needle, and Serono/Terumo customized 1 mL syringe with fixed 27G × 1/2 inch needle. Knowing that 1 mL Sterile Water for Injection, USP (SWI) weighs 1 gm, 1 mL SWI was drawn up in each syringe. The 1 mL SWI in each syringe was then expelled into a tube that was weighed before and after receiving the SWI, utilizing a highly sensitive AX204 Mettler Toledo-Sartorius balance. To detect any potential variation, the four syringes were weighed five times under the following three conditions during the trial: (A) syringe + needle, empty, (B) syringe + needle + 1 mL SWI, and (C) syringe + needle after delivering 1 mL SWI, as well as the weight of the SWI collected in the tube receptacle. The mean of these measurements per syringe was calculated. Results: After delivering 1 mL SWI the mean weight of the solution was 0.98 ± 0.02, 0.99 ± 0.005, 1.02 ± 0.015, and 0.99 ± 0.005 gm, for BD 3 mL, BD 1 mL, Monoject 1 mL and Serono/Terumo 1 mL, respectively. Hence, the same amount of solution was delivered by each syringe (mean 0.997 ± 0.002). The differences in the mean weight of the syringes before and after delivering the solution were 0.056 gm for BD 3mL (5.6%), 0.056 gm for BD 1 mL (5.6%), 0.028 gm for Monoject 1 mL (2.8%) and 0.002 gm for Serono/Terumo 1 mL (0.22%). These differences represent the solution that remains in the dead space of the syringe hub and in the cavity of the needle. Tabled 1 Conclusion(s): The results of this trial show that there is minimal variability in the amount of drug delivered by the syringes tested, although the most precise syringe delivering the most consistent dose as measured by Weights A and C was the Serono/Terumo customized syringe.
Read full abstract